Allergan plc (NYSE: AGN) is a large market cap stock with a market cap of 97363.8. It is in the Drugs – Generic industry and sector Healthcare, with a current P/E of *TBA, a forward P/E of 14.12 and EPS of -5.63. At a stock price of 241.82 (-1.07%) it has a dividend yield of 0.08%.
EPS growth for the last five years have been -50.40%, more recently this last year it has grown by 23.00%. The next year growth is going to be about 21.91% and more long-term 9.70% after five years. EPS growth quarter over quarter is 86.30%. Sales growth for the past five years have been 33.40% and sales growth quarter over quarter is 48.10%.
For performance, Allergan plc the past week has seen a gain of 2.58%. For the last month performance for Allergan plc is 3.01%. While the last quarter is 11.15% and half year, -17.21%. Finally for the year, performance is -22.70%.
The 52-week high for Allergan plc, is at -28.95%, and for the 52-week low it comes to a value of 23.69%. The 20-day simple moving average is 3.39% and -10.28% for the 200-day simple moving average.
Volatility for the week is at 1.86%, and for the month it is 2.35%. Allergan plc, has a target price of 293.06.
In terms of debt, long term debt/equity is 0.53, and for total debt/equity Allergan plc has 0.59. The gross margin is 71.80%, while operating margin is *TBA, the profit margin is *TBA. The current ratio is 1 and the quick ratio is 0.9.
Insider ownership is at 0.10%, with instituitional ownership at 89.90%. Allergan plc has a payout ratio of *TBA. With the total shares outstanding coming to 398.33. The shares float is 394.89, with the float short at 1.47%, with short ratio coming to 1.59.
In terms of returns, the return on assets see Allergan plc, get *TBA, with its returns on investment at -1.30%. Return on equity is *TBA. So will the investors see the target price of 293.06, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.